Cargando…

Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia

AIMS/HYPOTHESIS: We aimed to characterise the immunogenic background of insulin-dependent diabetes in a resource-poor rural African community. The study was initiated because reports of low autoantibody prevalence and phenotypic differences from European-origin cases with type 1 diabetes have raised...

Descripción completa

Detalles Bibliográficos
Autores principales: Balcha, Shitaye A., Demisse, Abayneh G., Mishra, Rajashree, Vartak, Tanwi, Cousminer, Diana L., Hodge, Kenyaita M., Voight, Benjamin F., Lorenz, Kim, Schwartz, Stanley, Jerram, Samuel T., Gamper, Arla, Holmes, Alice, Wilson, Hannah F., Williams, Alistair J. K., Grant, Struan F. A., Leslie, R. David, Phillips, David I. W., Trimble, Elisabeth R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476916/
https://www.ncbi.nlm.nih.gov/pubmed/32705316
http://dx.doi.org/10.1007/s00125-020-05229-x
_version_ 1783579793158045696
author Balcha, Shitaye A.
Demisse, Abayneh G.
Mishra, Rajashree
Vartak, Tanwi
Cousminer, Diana L.
Hodge, Kenyaita M.
Voight, Benjamin F.
Lorenz, Kim
Schwartz, Stanley
Jerram, Samuel T.
Gamper, Arla
Holmes, Alice
Wilson, Hannah F.
Williams, Alistair J. K.
Grant, Struan F. A.
Leslie, R. David
Phillips, David I. W.
Trimble, Elisabeth R.
author_facet Balcha, Shitaye A.
Demisse, Abayneh G.
Mishra, Rajashree
Vartak, Tanwi
Cousminer, Diana L.
Hodge, Kenyaita M.
Voight, Benjamin F.
Lorenz, Kim
Schwartz, Stanley
Jerram, Samuel T.
Gamper, Arla
Holmes, Alice
Wilson, Hannah F.
Williams, Alistair J. K.
Grant, Struan F. A.
Leslie, R. David
Phillips, David I. W.
Trimble, Elisabeth R.
author_sort Balcha, Shitaye A.
collection PubMed
description AIMS/HYPOTHESIS: We aimed to characterise the immunogenic background of insulin-dependent diabetes in a resource-poor rural African community. The study was initiated because reports of low autoantibody prevalence and phenotypic differences from European-origin cases with type 1 diabetes have raised doubts as to the role of autoimmunity in this and similar populations. METHODS: A study of consecutive, unselected cases of recently diagnosed, insulin-dependent diabetes (n = 236, ≤35 years) and control participants (n = 200) was carried out in the ethnic Amhara of rural North-West Ethiopia. We assessed their demographic and socioeconomic characteristics, and measured non-fasting C-peptide, diabetes-associated autoantibodies and HLA-DRB1 alleles. Leveraging genome-wide genotyping, we performed both a principal component analysis and, given the relatively modest sample size, a provisional genome-wide association study. Type 1 diabetes genetic risk scores were calculated to compare their genetic background with known European type 1 diabetes determinants. RESULTS: Patients presented with stunted growth and low BMI, and were insulin sensitive; only 15.3% had diabetes onset at ≤15 years. C-peptide levels were low but not absent. With clinical diabetes onset at ≤15, 16–25 and 26–35 years, 86.1%, 59.7% and 50.0% were autoantibody positive, respectively. Most had autoantibodies to GAD (GADA) as a single antibody; the prevalence of positivity for autoantibodies to IA-2 (IA-2A) and ZnT8 (ZnT8A) was low in all age groups. Principal component analysis showed that the Amhara genomes were distinct from modern European and other African genomes. HLA-DRB1*03:01 (p = 0.0014) and HLA-DRB1*04 (p = 0.0001) were positively associated with this form of diabetes, while HLA-DRB1*15 was protective (p < 0.0001). The mean type 1 diabetes genetic risk score (derived from European data) was higher in patients than control participants (p = 1.60 × 10(−7)). Interestingly, despite the modest sample size, autoantibody-positive patients revealed evidence of association with SNPs in the well-characterised MHC region, already known to explain half of type 1 diabetes heritability in Europeans. CONCLUSIONS/INTERPRETATION: The majority of patients with insulin-dependent diabetes in rural North-West Ethiopia have the immunogenetic characteristics of autoimmune type 1 diabetes. Phenotypic differences between type 1 diabetes in rural North-West Ethiopia and the industrialised world remain unexplained. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-020-05229-x) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
format Online
Article
Text
id pubmed-7476916
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-74769162020-09-21 Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia Balcha, Shitaye A. Demisse, Abayneh G. Mishra, Rajashree Vartak, Tanwi Cousminer, Diana L. Hodge, Kenyaita M. Voight, Benjamin F. Lorenz, Kim Schwartz, Stanley Jerram, Samuel T. Gamper, Arla Holmes, Alice Wilson, Hannah F. Williams, Alistair J. K. Grant, Struan F. A. Leslie, R. David Phillips, David I. W. Trimble, Elisabeth R. Diabetologia Article AIMS/HYPOTHESIS: We aimed to characterise the immunogenic background of insulin-dependent diabetes in a resource-poor rural African community. The study was initiated because reports of low autoantibody prevalence and phenotypic differences from European-origin cases with type 1 diabetes have raised doubts as to the role of autoimmunity in this and similar populations. METHODS: A study of consecutive, unselected cases of recently diagnosed, insulin-dependent diabetes (n = 236, ≤35 years) and control participants (n = 200) was carried out in the ethnic Amhara of rural North-West Ethiopia. We assessed their demographic and socioeconomic characteristics, and measured non-fasting C-peptide, diabetes-associated autoantibodies and HLA-DRB1 alleles. Leveraging genome-wide genotyping, we performed both a principal component analysis and, given the relatively modest sample size, a provisional genome-wide association study. Type 1 diabetes genetic risk scores were calculated to compare their genetic background with known European type 1 diabetes determinants. RESULTS: Patients presented with stunted growth and low BMI, and were insulin sensitive; only 15.3% had diabetes onset at ≤15 years. C-peptide levels were low but not absent. With clinical diabetes onset at ≤15, 16–25 and 26–35 years, 86.1%, 59.7% and 50.0% were autoantibody positive, respectively. Most had autoantibodies to GAD (GADA) as a single antibody; the prevalence of positivity for autoantibodies to IA-2 (IA-2A) and ZnT8 (ZnT8A) was low in all age groups. Principal component analysis showed that the Amhara genomes were distinct from modern European and other African genomes. HLA-DRB1*03:01 (p = 0.0014) and HLA-DRB1*04 (p = 0.0001) were positively associated with this form of diabetes, while HLA-DRB1*15 was protective (p < 0.0001). The mean type 1 diabetes genetic risk score (derived from European data) was higher in patients than control participants (p = 1.60 × 10(−7)). Interestingly, despite the modest sample size, autoantibody-positive patients revealed evidence of association with SNPs in the well-characterised MHC region, already known to explain half of type 1 diabetes heritability in Europeans. CONCLUSIONS/INTERPRETATION: The majority of patients with insulin-dependent diabetes in rural North-West Ethiopia have the immunogenetic characteristics of autoimmune type 1 diabetes. Phenotypic differences between type 1 diabetes in rural North-West Ethiopia and the industrialised world remain unexplained. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-020-05229-x) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2020-07-23 2020 /pmc/articles/PMC7476916/ /pubmed/32705316 http://dx.doi.org/10.1007/s00125-020-05229-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Balcha, Shitaye A.
Demisse, Abayneh G.
Mishra, Rajashree
Vartak, Tanwi
Cousminer, Diana L.
Hodge, Kenyaita M.
Voight, Benjamin F.
Lorenz, Kim
Schwartz, Stanley
Jerram, Samuel T.
Gamper, Arla
Holmes, Alice
Wilson, Hannah F.
Williams, Alistair J. K.
Grant, Struan F. A.
Leslie, R. David
Phillips, David I. W.
Trimble, Elisabeth R.
Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia
title Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia
title_full Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia
title_fullStr Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia
title_full_unstemmed Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia
title_short Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia
title_sort type 1 diabetes in africa: an immunogenetic study in the amhara of north-west ethiopia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476916/
https://www.ncbi.nlm.nih.gov/pubmed/32705316
http://dx.doi.org/10.1007/s00125-020-05229-x
work_keys_str_mv AT balchashitayea type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia
AT demisseabaynehg type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia
AT mishrarajashree type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia
AT vartaktanwi type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia
AT cousminerdianal type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia
AT hodgekenyaitam type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia
AT voightbenjaminf type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia
AT lorenzkim type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia
AT schwartzstanley type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia
AT jerramsamuelt type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia
AT gamperarla type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia
AT holmesalice type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia
AT wilsonhannahf type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia
AT williamsalistairjk type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia
AT grantstruanfa type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia
AT leslierdavid type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia
AT phillipsdavidiw type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia
AT trimbleelisabethr type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia